A novel, high sensitivity marker of cartilage formation was developed and tested in a phase ii clinical trial of PTH. (April 2017) - Luo, Y.Y.; He, Y.; Byrjalsen, I.; Henriksen, K.; Gudmann, N.S.; Mobasheri, A.; Hansen, G.; Karsdala, M.; Bay-Jensen, A.C.